Article
The Role of the Surgeon in the Germline Testing of the Newly Diagnosed Breast Cancer Patient.
Current oncology (Toronto, Ont.) - 1 May 2023
Schick Stephanie, Manghelli Joshua, Ludwig Kandice K
Abstract excerpt
For patients with newly diagnosed breast cancer, information regarding hereditary predisposition can influence treatment decisions. From a surgical standpoint, patients with known germline mutations may alter decisions of local therapy to reduce the risk of second breast primaries. This information may also be considered in the choice of adjuvant therapies or eligibility for clinical trials. In recent years, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
